New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
13:49 EDTRTRXRetrophin notifies Chenodal wholesaler of price increase
Retrophin disclosed in a regulatory filing that the company provided notice to the wholesaler of its Chenodal product that, effective immediately, Retrophin had increased the price of a package of 100 250mg tablets of Chenodal from $9,460 to $47,300.
News For RTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2015
07:11 EDTRTRXLeerink to hold a roundtable
Subscribe for More Information
September 23, 2015
06:29 EDTRTRXOrphan drug pricing concerns overdone, says Leerink
Leerink analyst Joseph Schwartz says his firm's Orphan Drug Payor survey contrasts with the recent bearish investor sentiment over the orphan drug business model. The survey of 30 payors indicates that the reimbursement landscape "remains highly favorable" for commercially insured patients and is able to withstand potential weakness caused by proposed changes to Medicare pricing, Schwartz tells investors in a research note. His analysis suggests a "surprisingly limited" impact to valuations of orphan drug companies should Medicare patients receive drug discounts. Schwartz views the pricing concerns stemming from Hillary Clinton's plan to combat high drug prices as overdone. He reiterates Outperform ratings on AMAG Pharmaceuticals (AMAG), BioMarin (BMRN), Raptor Pharmaceuticals (RPTP) and Retrophin (RTRX).
September 22, 2015
06:19 EDTRTRXClinton to roll out plan to rein in prescription drug costs, USA Today reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use